Ginkgo Bioworks
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $89,046 | $56,206 | $37,944 | $34,755 |
Gross Profit | 79,059 | 25,155 | 15,873 | 18,807 |
EBITDA | -55,204 | -136,945 | -165,133 | -269,129 |
EBIT | -154,275 | -178,002 | -281,966 | |
Net Income | -56,403 | -217,181 | -165,911 | -211,694 |
Net Change In Cash | 89,046 | 56,206 | 37,944 | 34,755 |
Free Cash Flow | -118,590 | -111,422 | -95,969 | -52,000 |
Cash | 616,214 | 730,367 | 843,768 | 944,073 |
Basic Shares | 52,246 | 51,375 | 50,133 | 50,032 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $251,455 | $477,706 | $313,837 | $76,657 |
Gross Profit | 197,450 | 273,490 | 184,147 | 61,046 |
EBITDA | -821,293 | -2,059,659 | -1,877,571 | -108,585 |
EBIT | -892,847 | -2,121,293 | -1,877,807 | -122,449 |
Net Income | -892,869 | -2,104,929 | -1,836,642 | -126,609 |
Net Change In Cash | 251,455 | 477,706 | 313,837 | 76,657 |
Cost of Revenue | -224,255 | 1,207,070 | ||
Free Cash Flow | -336,301 | -304,469 | -310,339 | -193,651 |
Cash | 944,073 | 1,315,792 | 1,550,004 | 380,801 |
Basic Shares | 48,610 | 41,995 | 1,611,392 | 1,485,061 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$1.08 |
2024-06-30 | -$4.40 |
2024-03-31 | -$0.08 |
2023-12-31 | -$0.11 |
